|
HS Code |
477892 |
| Chemicalname | Ethyl 2-(3-Formyl-4-Isobutoxyphenyl)-4-Methylthiazole-5-Carboxylate |
| Molecularformula | C18H21NO4S |
| Molecularweight | 347.43 g/mol |
| Casnumber | 1336271-62-9 |
| Appearance | Light yellow solid |
| Purity | ≥98% (HPLC) |
| Meltingpoint | 98-102°C |
| Solubility | Soluble in DMSO, DMF, methanol |
| Storagetemperature | -20°C |
| Smiles | CCOC(=O)C1=NC(=C(S1)C)C2=CC(=C(C=C2)C=O)OCC(C)C |
| Inchikey | QJDZGFQZIGHJNI-UHFFFAOYSA-N |
As an accredited Ethyl 2-(3-Formyl-4-Isobutoxyphenyl)-4-Methylthiazole-5-Carboxylate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Amber glass bottle containing 25 grams of Ethyl 2-(3-Formyl-4-Isobutoxyphenyl)-4-Methylthiazole-5-Carboxylate, labeled with chemical name and hazard symbols. |
| Shipping | Ethyl 2-(3-Formyl-4-Isobutoxyphenyl)-4-Methylthiazole-5-Carboxylate is shipped in secure, chemical-resistant containers, compliant with safety and regulatory standards. The package is clearly labeled, protected from moisture and light, and handled as a non-hazardous chemical unless otherwise specified. Shipping methods ensure temperature stability and product integrity throughout transit. |
| Storage | **Storage Description for Ethyl 2-(3-Formyl-4-Isobutoxyphenyl)-4-Methylthiazole-5-Carboxylate:** Store in a cool, dry, and well-ventilated area, away from direct sunlight, heat sources, and incompatible materials such as strong acids or oxidizers. Keep container tightly closed and clearly labeled. Use appropriate secondary containment to prevent leaks or spills. Follow standard laboratory safety protocols when handling and storing this chemical. |
Applications of Ethyl 2-(3-Formyl-4-Isobutoxyphenyl)-4-Methylthiazole-5-Carboxylate in Industrial ManufacturingEthyl 2-(3-Formyl-4-Isobutoxyphenyl)-4-Methylthiazole-5-Carboxylate serves as a specialized intermediate across multiple advanced fine chemical manufacturing domains. Its functional groups enable targeted synthetic steps, making it suitable for pharmaceutical APIs, specialty agrochemical actives, advanced material coatings, and select fragrance formulary development. As a direct manufacturer, we ensure purity and consistency for complex downstream conversion processes. 1. Pharmaceutical Intermediates SynthesisOur material is employed in the multi-step synthesis of heterocyclic drug intermediates, particularly as a key building block for thiazole-based compounds present in various regulated APIs. R&D and GMP production lines integrate this molecule during the condensation stage, leveraging its functionalized aromatic aldehyde and ester motifs to facilitate controlled cyclization and further transformation under defined pH and temperature conditions. End users frequently deploy our intermediate in the preparation of anti-infective and CNS-active pharmaceutical substances. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Specialty Agrochemical Active Ingredient ManufacturingDownstream agrochemical formulators leverage this thiazole derivative for constructing isobutoxyphenyl scaffolds used in fungicidal and herbicidal agents. The molecule enters synthetic routes that yield novel active ingredients with improved selectivity and environmental safety profiles. Process engineers precisely control stoichiometry and solvent systems to maximize product throughput while meeting purity benchmarks for crop protection registrations. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Functional Material Coatings SynthesisManufacturers of advanced coatings use this compound for synthesizing polymer-modified thiazole derivatives imparting tailored chemical resistance and UV stability to end-use coatings. The raw material undergoes esterification or ring-opening reactions, integrating into specialty resins used in electronics and industrial metal finishing sectors, where resistance to aggressive chemical environments is critical. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Fragrance Ingredient SynthesisA select group of fragrance manufacturers utilize this molecule within the aldehyde–thiazole sub-family to synthesize perfumery intermediates targeting woody, spicy, and floral accords. The raw material enters controlled condensation routes that build customized aroma compounds for high-end fine fragrance or flavor formulations, with batch traceability and organoleptic purity closely maintained during small-lot production. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Ethyl 2-(3-Formyl-4-Isobutoxyphenyl)-4-Methylthiazole-5-Carboxylate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Ethyl 2-(3-Formyl-4-Isobutoxyphenyl)-4-Methylthiazole-5-Carboxylate represents the culmination of years forging synthesis pathways and refining product consistency in an industry where purity affects everything downstream. We manufacture this thiazole-based intermediate because chemical innovation relies on a foundation of building blocks that don’t just work, but excel. Many partners depend on intermediates they can trust batch after batch, especially in busy R&D pipelines and large-scale drug synthesis.
We synthesize and supply the most widely demanded model, featuring a thiazole core linked to an aromatic ring with both formyl and isobutoxy groups. This unique scaffold provides key functional handles for downstream reactions—particularly condensation, cyclization, and cross-coupling steps popular in medicinal chemistry. Over time, we have fine-tuned our process to yield a compound with high assay and minimal related substance content, using a combination of column purification techniques and rigorous analytical checks.
This intermediate leaves our plant as a pale yellow solid, with an assay consistently above industry expectations due to a controlled crystallization process. We take every batch through HPLC, NMR, and LC-MS, so our chemists quickly spot variances before packing even starts. Moisture control proves essential for long-term integrity, so storage environments stay below a tightly held limit—we’ve seen degradation risks firsthand when moisture creeps in, so our shipping and on-site storage demand diligence.
R&D teams, pilot plant chemists, and scale-up managers speak often about bottlenecks caused by variable intermediates. By listening to projects that ran into unexpected purification hurdles, we made process tweaks that brought down impurity profiles. The result isn’t just a matter of cleaner HPLC, but smoother downstream steps. In applications, the formyl group reliably participates in C–C bond-forming processes, and the isobutoxy moiety enhances solubility for certain solvents—something often missed in purely theoretical analysis.
In our own circles, talk of consistency goes deeper than just hitting published specs. Industry partners can plan multistep syntheses with shorter timelines—there’s less re-testing, and fewer surprises during scale-up. Our experiences with a wide range of customers, from process chemists making gram batches up to manufacturers running tonne-scale, highlight a real-world difference: repeatable results. Small variances cause wasted time and materials on the customer end, so our investment in process control pays off far beyond our walls.
Diversity in structure enables creative thinking in drug design or new materials discovery. Most intermediates resemble the “usual suspects”—straightforward aldehydes or simple aromatic compounds. Ethyl 2-(3-Formyl-4-Isobutoxyphenyl)-4-Methylthiazole-5-Carboxylate brings a balance of reactivity with stability. The five-membered thiazole ring can tolerate conditions during multi-step synthesis and doesn’t break down readily under moderate acid or base. That reliable core lets medicinal chemists work with confidence, taking advantage of both the nucleophilic and electrophilic sites.
Some alternatives lack the structural richness needed for next-generation compounds. For example, simple aromatic aldehydes can’t offer the same functional group density, so the range of modifications stays limited. If you try to use a molecule without the isobutoxy sidechain, solubility often drops—difficult to dissolve, harder to process, and prone to uneven reactions, especially in less polar solvents. Modifying with bulkier groups hits problems later with steric hindrance, while undersized scaffolds compromise selectivity or downstream utility.
We learned the hard way, through both internal and customer pilot runs, that this thiazole ester remains robust under a variety of standard reaction sequences. Operations run smoother in Suzuki, Heck, and Knoevenagel condensations, and less time is spent troubleshooting insolubility or decomposition. The carboxylate ester not only delivers convenient reactivity but is stable enough to withstand storage and moderate heat—a real plus for manufacturers who face global supply chain delays.
Medicinal chemists put this intermediate to work as a scaffold for kinase inhibitor programs and as an advanced starting material for non-linear drug candidates. For agrochemical innovators, the same core structure forms the backbone of some experimental herbicides and insect-resistance molecules, leveraging the electron-withdrawing aldehyde for downstream selective transformations. In custom synthesis, CRO project leads appreciate reliable delivery of “hard-to-find” intermediates, letting their teams stay focused on discovery, not procurement headaches or last-minute substitutions.
Our plant has shipped this compound into multi-continent drug discovery pipelines. In one pharmaceutical project aiming to optimize metabolic stability, this intermediate enabled a key anchor point for diversification—multiple analogs could be prepared by functionalizing the aromatic core or thiazole, accelerating structure-activity relationship studies by weeks. In another example, a customer making novel fluorescent labeling reagents praised the clean background in TLC and MS, allowing rapid progress without needing extensive purification.
Even the smallest impurities left in a batch can sidetrack expensive projects. Through experience, we caught that some earlier synthetic routes left behind difficult-to-remove byproducts—chlorinated aromatics or oligomeric residues, both of which complicated downstream processing. Our manufacturing team ran controlled trials to refine the workup, swapping out certain reagents and introducing an anti-solvent precipitation step that cut these trace contaminants down by over ninety percent. This discipline now shows in our certificate of analysis and, more importantly, in our repeat orders from returning partners.
Scaling up from pilot batches unearthed other challenges. We saw that temperature swings altered crystal morphology, which affected drying efficiency and the ease with which the product could be handled or re-dissolved. So, our production adopted a new cooling profile and implemented in-line monitoring by laser scattering, leading to finer, free-flowing product. Customers in high-throughput research labs, where every extra filtration step burns time, gain from this improvement with less downtime and more manageable reaction set-ups.
Supply disruptions in specialty intermediates can stifle entire projects. Many customers want to lock in multi-kilo lots but face unpredictability unless the manufacturer runs dependable capacity and back-up stores. We’ve experienced this ourselves—global feedstock fluctuations throw off forecasts unless close partnerships with raw material suppliers are maintained. By securing long-term agreements for key inputs and running staggered production cycles, our plant sustains output through both demand spikes and logistical snags. Direct relationships and vertical integration mean that priorities at the root matter more than last-minute firefighting.
Years ago, traceability drew less attention, but today regulatory and audit-ready documentation carries new weight. Every lot leaving our facility comes with a thorough batch record, full testing summary, and route-of-synthesis confirmation. Our own process engineers manage document retention and digital backups, making later reference seamless for any customer needing to track project lineage.
Sustainability questions come up more often now, and we acknowledge both the progress and shortfalls the chemical industry faces. In this product’s route, we’ve reduced halogenated solvent use, moved to water-based wash steps where feasible, and set up solvent recovery for mother liquors. By-products from this synthesis stream into our on-site waste treatment system, where advanced oxidation and in situ monitoring keep emissions well below regulatory limits. It’s an ongoing journey, but customers and regulators expect—and deserve—progress over complacency.
Manufacturing intermediates like Ethyl 2-(3-Formyl-4-Isobutoxyphenyl)-4-Methylthiazole-5-Carboxylate calls for more than technical recipes pulled from the literature. Scaling up, running quality through tight windows, and shipping globally challenge any lab protocol. Customers regularly tell us they’ve been burned when purchasing intermediates from traders or unverified sources—mystery impurities, mismatched appearance, incomplete documentation. Our in-house process was built and proven on our equipment, not reverse-engineered or repackaged. In the end, traceable quality stands out only if the original process is understood and controlled from top to bottom.
Pressure to drop prices or switch to cheaper reagents never fails to appear. We witness what happens when competitors take shortcuts—batches fail in late-stage processing for other companies, and key data gets questioned in regulatory filings. For our team, every process tweak gets validated by running full test reactions and comparing to control standards. Our QA unit rejects any lot outside published limits, even if that means absorbing production losses. We have built our reputation by holding this line even as prices for starting materials shift.
Requests come in from academic labs looking for just a few grams, as well as pharmaceutical plants requiring drum-scale deliveries. Both value speed, transparent pricing, and above all, consistent product performance. By running both campaign and made-to-order batches, our team adapts to surges in demand without sacrificing quality for speed. On-site analysts sign off on each lot, and proactive communication with customer chemists helps us anticipate any custom purification needs, packing formats, or documentation requirements.
The strengths of this intermediate reflect in the diversity of projects it supports. In drug discovery, it lets scientists explore chemical space efficiently—multiple analogs spring from a single, stable core. In diagnostics, researchers create labeled derivatives that retain clarity in spectroscopic readouts. In agroscience, lead compounds with better environmental profiles and longer field durations arise by modifying the parent molecule from this starting point.
Experienced formulators highlight the benefit of our compound’s solubility profile. By carrying the isobutoxy group, researchers enjoy a broader solvent range for both preparative HPLC and crystal screening. That advantage has launched new methodologies in lab after lab, as chemists typically face trade-offs between scaffold stability and downstream solubility—this intermediate allows both without compromise.
Behind each gram shipped, our line chemists and engineers monitor not just the yield, but minute-by-minute process readings—temperature, pH, and flow rates—ensuring full compliance with SOPs and regulatory expectations. In-process checks allow quick adjustments, and support from experienced supervisors means that questions about scale-specific quirks never go unresolved. Continuous feedback loops from quality control and customer end-use help guide ongoing refinement—if a unique impurity appears one day, the next batch already shows process improvement.
No two production runs are identical, and laboratory “clean” reactions often break down when uncorked at industrial scale. Early scale-ups of this intermediate taught us that pressure differentials across filters sometimes leave behind microcrystals—not easily visible, but insidious when stability matters. To counter this, our team introduced high-shear mixing at specified points, a tweak overlooked by basic protocols, but one that solidified quality in every lot.
Shipping intermediates over thousands of kilometers presents hurdles with temperature swings, customs holdups, and handling mistakes. Working directly with logistics partners, ensuring tamper-evident packaging, and providing clear storage recommendations give our clients one less variable to worry about. By monitoring shipments and offering responsive support, we guard the value built during production all the way to the user’s bench.
We invite customer input openly—successful syntheses and challenges alike. One leading project hit a wall with an impurity not evident under legacy conditions; our QC picked up a mass trace, prompting us to adjust silica grade in column workup. This joint troubleshooting not only fixed the project but sharpened our team’s troubleshooting capability for future runs. Our continuous improvement depends on honest conversations and technical collaboration, not just transaction-driven exchanges.
The chemical industry advances on shared technical insight—proprietary data, yes, but also real-world application stress tests. Open communication between actual manufacturers and the discovery teams using our intermediate leads to tangible benefits at every stage from chemical design to regulatory submission. We view ourselves as a technical partner, not just a supplier.
As innovation cycles tighten and confidence in supply chain traceability grows in importance, intermediates like Ethyl 2-(3-Formyl-4-Isobutoxyphenyl)-4-Methylthiazole-5-Carboxylate will play larger roles in high-value syntheses. By standing firmly behind every lot with proven process knowledge, robust documentation, and a long-term view, we support those bringing new therapies, materials, and technologies to market. Our experience as a direct manufacturer continues to anchor both our quality and our commitment to the scientists moving the field forward.